Value of miR-21 and miR-141 in Evaluating the Efficacy and Prognosis of Thoracoscopic Lobectomy for Early-Stage Lung Cancer in the Elderly

DOI: https://doi.org/10.62517/jmhs.202405118

Author(s)

Tao Zhang

Affiliation(s)

Department of Cardiothoracic Surgery, Shiyan Remin Hospital, Shiyan, Hubei, China

Abstract

The effectiveness and prognosis of thoracoscopic lobectomy in sennior individuals with early-stage cancer were evaluated by assessing the value of microRNAs (miR)-21 and miR-141. A total of 116 sennior individuals with early-stage cancer were divided into two cohorts based on the surgical effect: the observation cohort (effective) and the control cohort (ineffective). Moreover, 80 healthy individuals who underwent medical examination were selected as the comparison cohort B. The levels of serum miR-141serum miR-21 and were assessed in all participants. The comparison revealed that the highest levels of these two serum biomarkers were observed in control cohort A, followed by the observation cohort, and the lowest levels were found in control cohort B (P<0.05). The receiver operating characteristic curve (ROC) analysis showed that the area under the curve for individual assessment of miR-141 and miR-21 in predicting efficacy and prognosis were 0.838 and 0.740, respectively. The sensitivity and specificity for miR-21 were 85.3% and 76.2%, respectively, while for miR-141, they were 53.7% and 85.1%, respectively. These findings suggest that serum miR-21 and serum miR-141 are closely associated with postoperative efficacy and prognosis in individuals with early-stage cancer. Both miR-141 and miR-21 can serve as biomarkers for evaluating effectiveness and prognosis.

Keywords

MicroRNA-21; MicroRNA-14; Early-stage Lung Cancer; Thoracoscopic Lobectomy; Efficacy; Prognosis

References

[1] Fu Chunyan, Huang Yi, Jiang Li. Diagnostic value of combined detection of tumor markers and cytokines for early lung adenocarcinoma J Practical Hospital Clinical Journal, 2023, 20(4): 158-161. [2] Wang Junqing, Yan Di, Mao Rui. The value of low-dose spiral CT combined with serum VEGF, CEA, and CA125 level detection in the diagnosis of early lung cancer J Journal of Practical Cancer, 2023, 38(3): 418-421. [3] Wang Zhaochun, Wang Pengfei. Expression and meaning of microRNA in serum and tumor tissue of patients with colon cancer J Laboratory Medicine and Clinic,2017,14(24):3684-3685. [4] Chinese Lung Cancer Prevention and Treatment Alliance, Lung Cancer Research Group of the Respiratory Medicine Branch of the Chinese Medical Association, Lung Cancer Working Committee of the Respiratory Physicians Branch of the Chinese Medical Doctor Association. Chinese expert consensus on lung cancer screening and management J International Respiratory Journal,2019, 39(21):1604-1615. [5] Li WM, Zhao S, Liu LX. [The Methods and Clinical Significance of Early Diagnosis of Lung Cancer]J Sichuan Da Xue Xue Bao Yi Xue Ban. 2017,48(3):331-335. [6] Yao Shuyang, Zhang Yi. Research progress in monitoring minimal residual disease after early stage lung cancer surgery using circulating tumor DNA J Journal of Oncology, 2023, 29(1): 66-70.. [7] Oncology Branch of the Chinese Medical Doctor Association, Medical Oncology Branch of the China Association for the Promotion of International Healthcare Exchange. Chinese Treatment Guidelines for Stage IV Primary Lung Cancer (2023 Edition) J Chinese Journal of Oncology, 2023, 45(1):1 -30. [8] Yu Wei. Analysis of the effect of thoracoscopic surgery in the treatment of early stage lung cancer in the sennior and its impact on postoperative oxidative stress J Central South Journal of Medical Sciences,2018,46(5):535-537. [9] Mao Jun, Wang Ke. Study on the correlation between blood CRP, D-dimer, IL-17 levels and concurrent acute respiratory failure in sennior patients with lung cancer after pneumonectomy J Journal of Modern Laboratory Medicine,2021,36(3):83-87. [10] Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases J Nat Rev Drug Discov,2017,16(3):203-222. [11] Wang Ziqi, Zhao Jinglong, Shi Qiusheng. Research progress of miRNA in the diagnosis and treatment of prostate cancer J International Journal of Biomedical Engineering, 2022, 45(3): 280-285. [12] Gao Yan, Xin Wenyan, Wang Bei, et al. MicroRNA?708 targets the expression of FOXO3 and affects the proliferation, invasion and migration of non-small cell lung cancer cells J Journal of Clinical Oncology,2019,24(10):886-890. [13] Niu Fanglei, Liu Hongxia. Study on the evaluation value of serum miR-21 and miR-145 expression levels in the evaluation of chemotherapy effect and prognosis of individuals with ovarian cancer J Laboratory Medicine and Clinic, 2023, 20(13): 1850-1854. [14] Hao Wentao, Yang Yaling, Zhang Haiyan. Analysis of expression characteristics of plasma miRNA-200b and miRNA-21 in serous ovarian cancer J Journal of Practical Cancer,2019,34(7):1072-1075. [15] Shen Zilong, Cheng Fuli, Zhang Linfeng. Expression and clinical meaning of miR-21, miR-221, and miR-106 a in children's osteosarcoma tissues J Journal of Practical Cancer,2021,36(8):1249-1252. [16] Wang Xuelin, Liu Yixiang. Serum miR-200b and miR-141 expression in sennior individuals with lung cancer and their impact on prognosis J Guangdong Medicine,2019,40(21):3040-3044. [17] Ma Ling, Li Haiming, Zhai Zhanyi, et al. Detection of the expression levels of miR-141 and KLF9 in non-small cell lung cancer and their effects on cell proliferation and invasion J Journal of Clinical Pulmonology,2021,26(5):762-766. [18] Liu Hongyun, Zhang Shuguang, Yu Sihai. Analysis of the relationship and joint predictive value of miR-21, Cyr61 mRNA, miR-141 and recurrence after minimally invasive thoracoscopic lung cancer surgery J Journal of PLA Medicine,2021,33(9):17-21.